Summary
- Current Price
- As of today, LXEO price is $3.00, down -0.66% on
- Current Price All-Time High
- LXEO price is currently -86.57% below its historical high of $22.33 set on
- Market Cap
- LXEO current market cap is $246M, down -53.30% year-over-year
- Revenue
- LXEO current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for LXEO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Lexeo Therapeutics, Inc. |
| Ticker | NASDAQ: LXEO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | lexeotx.com |
| Employees | 75 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $3.00 | |
| Price, 1D Change | -0.66% | |
| $246M | ||
| - | ||
| - | ||
| 2.04 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.86 | ||
| EPS, 1Y Change | +39.76% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.86 | ||
| EPS Estimate | -$1.20 | N/A |
| EPS Est. Change | +35.68% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $3.00 | |
| Price Target | $20.00 | - |
| Price Tgt. Change | +566.67% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.09 | -$3.09 | -0.16% | |
| -$1.92 | -$1.86 | +3.06% | |
| -$1.20 | N/A | +35.68% | |
| -$1.37 | N/A | +26.34% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $3.00 | |
| $5.42 | ||
| $4.04 | ||
| $5.09 | ||
| $3.76 | ||
| -$0.34 | ||
| 2.04 | ||
| $0.26 | ||
| 39.47 | ||
| 92.25% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.86 | ||
| -$2.08M | ||
| - | ||
| -$109.26M | ||
| - | ||
| -$99.96M | ||
| - | ||
| -$107.18M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.03 | ||
| 11.21 | ||
| 11.21 | ||
| - | ||
| - | ||
| 3.51 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 1.05 | ||
| -0.45 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $246.67M | ||
| $181.77M | ||
| $271.13M | ||
| $188.39M | ||
| $24.46M | ||
| $16.81M | ||
| $7.89M | ||
| $2.68M | ||
| $4.86M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $99.96M | ||
| $107.18M | ||
| $2.08M | ||
| $0.00 | ||
| $2.08M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$98.56M | ||
| -$90.25M | ||
| $216.80M | ||
| $397.00K | ||
| -$98.96M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Leerink Partners | → | |
| JP Morgan | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Raymond James | ||
| Chardan Capital | → | |
| Cantor Fitzgerald | ||
| Cantor Fitzgerald | ||
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
No data
Screeners with LXEO
FAQ
- What is the ticker symbol for Lexeo Therapeutics, Inc.?
- The ticker symbol for Lexeo Therapeutics, Inc. is NASDAQ:LXEO
- Does Lexeo Therapeutics, Inc. pay dividends?
- No, Lexeo Therapeutics, Inc. does not pay dividends
- What sector is Lexeo Therapeutics, Inc. in?
- Lexeo Therapeutics, Inc. is in the Healthcare sector
- What industry is Lexeo Therapeutics, Inc. in?
- Lexeo Therapeutics, Inc. is in the Biotechnology industry
- What country is Lexeo Therapeutics, Inc. based in?
- Lexeo Therapeutics, Inc. is headquartered in United States
- When did Lexeo Therapeutics, Inc. go public?
- Lexeo Therapeutics, Inc. initial public offering (IPO) was on November 3, 2023
- Is Lexeo Therapeutics, Inc. in the S&P 500?
- No, Lexeo Therapeutics, Inc. is not included in the S&P 500 index
- Is Lexeo Therapeutics, Inc. in the NASDAQ 100?
- No, Lexeo Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Lexeo Therapeutics, Inc. in the Dow Jones?
- No, Lexeo Therapeutics, Inc. is not included in the Dow Jones index
- When was Lexeo Therapeutics, Inc. last earnings report?
- Lexeo Therapeutics, Inc.'s most recent earnings report was on August 12, 2026
- When does Lexeo Therapeutics, Inc. report earnings?
- The next expected earnings date for Lexeo Therapeutics, Inc. is November 4, 2026
Data Sources & References
- LXEO Official Website www.lexeotx.com
- LXEO Profile on Yahoo Finance finance.yahoo.com/quote/LXEO
- LXEO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lxeo